If approved, clesrovimab would be the first and only FDA approved single dose immunization for infants approved in time for ...

Merck's clesrovimab is an immunization aimed at protecting infants from respiratory syncytial virus, or RSV, disease. "Merck Gets FDA Review of Clesrovimab RSV Vaccine Candidate," at 7:26 a.m. ET, ...

Vaccinations provide significant protection for the public against infectious diseases and substantially reduce health care ...

Merck said on Monday it has discontinued the development of two experimental cancer drugs after their failure in several ...

Merck & Co. on Tuesday said the Food and Drug Administration has accepted its application seeking approval of its proposed clesrovimab vaccine aimed at protecting infants from respiratory syncytial ...

An FDA approval of Merck’s drug clesrovimab by June would give physicians another option for protecting newborns from ...

Rabies is a deadly viral infection that spreads in the saliva of infected animals. When a rabid animal bites another animal ...

IntroductionThe veterinary vaccines market plays a crucial role in global animal health, ensuring the prevention of ...

The veterinary vaccines market is experiencing robust growth driven by factors such as the rising prevalence of zoonotic ...

In addition, increase in meat and milk consumption and rise in the emergence of zoonotic diseases supplement the animal vaccines market growth. Veterinary vaccines play a significant role in the ...

According to a new market research report, ' Viral Vaccines Market Size, Share, Forecast, & Trends Analysis by Form (Liquid, ...